1. Home
  2. VRRM vs SYRE Comparison

VRRM vs SYRE Comparison

Compare VRRM & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Verra Mobility Corporation

VRRM

Verra Mobility Corporation

HOLD

Current Price

$18.67

Market Cap

3.0B

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$33.56

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRRM
SYRE
Founded
1987
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Transportation Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.6B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
VRRM
SYRE
Price
$18.67
$33.56
Analyst Decision
Buy
Strong Buy
Analyst Count
5
6
Target Price
$27.70
$56.50
AVG Volume (30 Days)
1.5M
591.6K
Earning Date
02-24-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.32
N/A
Revenue
$942,717,000.00
N/A
Revenue This Year
$11.68
N/A
Revenue Next Year
$6.32
N/A
P/E Ratio
$58.26
N/A
Revenue Growth
8.52
N/A
52 Week Low
$17.08
$10.91
52 Week High
$26.89
$35.58

Technical Indicators

Market Signals
Indicator
VRRM
SYRE
Relative Strength Index (RSI) 28.50 53.23
Support Level $18.35 $30.92
Resistance Level $19.02 $35.58
Average True Range (ATR) 0.75 1.86
MACD -0.15 0.02
Stochastic Oscillator 27.81 55.42

Price Performance

Historical Comparison
VRRM
SYRE

About VRRM Verra Mobility Corporation

Verra Mobility Corp is a provider of smart mobility technology solutions, principally operating throughout the United States, Australia, Europe and Canada. The company develops and uses technology and data intelligence to help make transportation safer and easier. It operates in three segments namely Commercial Services, Government Solutions, and Parking Solutions. It generates maximum revenue from the Commercial Services segment. The commercial Services segment delivers tolling and violation management services to rental car companies, commercial fleet vehicle owners, and violation issuing authorities.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: